| FCN-437 / Fosun Pharma |
| Completed | 1 | 22 | US | FCN-437 | Fochon Pharmaceuticals, Ltd. | Solid Tumor, Adult | 12/21 | 12/21 | | |
ChiCTR2200059507: A single-center, open-label and sequential-dosing clinical trial investigating the drug interaction between FCN-437c capsule and itraconazole capsule or rifampicin capsule in healthy adult subjects |
|
|
| Not yet recruiting | 1 | 48 | | FCN437c 100mg was taken orally on an empty stomach for Day1, 200mg itraconazole was taken orally after meals for Day13 to Day16 and Day18 to Day24, and FCN437c 100mg and 200mg itraconazole were taken orally on an empty stomach for Day17 ;FCN437c 200mg was taken orally on an empty stomach for Day1, 600mg of Rifampicin was taken orally on an empty stomach for Day13 to Day19 and Day21 to Day27, and FCN437c 200mg and 600mg of Rifampicin were taken orally on an empty stomach for Day20 | The Second Hospital of Anhui Medical University; The Second Hospital of Anhui Medical University, AVANC PHARMACEUTICAL CO., LTD. | N/A | | | | |
NCT06290466: Clinical Study on Pharmacokinetics of FCN-437c Capsule and Its Effect on QT Interval in Healthy Subjects |
|
|
| Completed | 1 | 18 | RoW | Low dose group, FCN-437c capsule or FCN-437c capsule Placebo, High dose group | Ahon Pharmaceutical Co., Ltd. | Advanced Breast Cancer | 02/23 | 02/23 | | |
ChiCTR2200063689: A single-center, randomized, open, two-cycle, crossover designed Phase I study was conducted to evaluate the pharmacokinetic characteristics and safety of food effect on single oral administration of FCN-437C capsules in healthy Chinese adults |
|
|
| Not yet recruiting | 1 | 24 | | High ester meal ;High ester meal | Peking University Third Hospital; Peking University Third Hospital, AVANC PHARMACEUTICAL CO.,LTD | NA | | | | |
| Not yet recruiting | 1 | 6 | | Single oral administration | The First Affiliated Hospital of Soochow University; AVANC PHARMACEUTICAL CO., LTD, AVANC PHARMACEUTICAL CO.,LTD | NA | | | | |
ChiCTR2200065512: A single-center, randomized, double-blind, placebo-controlled, phase I study was conducted to evaluate the pharmacokinetics and effect on QT interval of a single oral dose of FCN-437c capsule in healthy subjects |
|
|
| Not yet recruiting | 1 | 18 | | Single oral administration ;Single oral administration ;Oral placebo | Peking University Third Hospital; Peking University Third Hospital, AVANC PHARMACEUTICAL CO.,LTD | NA | | | | |
